Oncotype DX AR-V7 Nucleus Detect® test: Testing process

Fast results from a simple blood test

The AR-V7 Nucleus Detect® test only requires a simple blood draw at your doctor’s office or nearby lab. About 2 weeks after Exact Sciences* receives your blood draw, your results will be available to your doctor.

The results will say your tumor is either AR-V7 positive (AR-V7+) or AR-V7 negative (AR-V7-). An AR-V7+ result means your tumor will not respond to AR-targeted therapies and you should consider other treatments instead.

 

Has your doctor ordered the AR-V7 Nucleus Detect test for you? 

This webinar explains what mCRPC is and how the results can help with your treatment decision.

Talking to your doctor about the AR-V7 Nucleus Detect test

Like other lab tests, the AR-V7 Nucleus Detect test must be ordered by a licensed healthcare provider (like your doctor). Whether you decided to get the test or not, you’ll certainly have a lot to talk about with your doctor.

Here are some questions you may want to ask:

  • If I am a candidate for the AR-V7 Nucleus Detect test, how could we use the results to develop my treatment plan?
  • What are my treatment options? What do you suggest for me and why?
  • How long do side effects of each treatment option last? Do they go away once treatment is complete?
  • What are the benefits of each treatment option? What are the drawbacks/side effects of each one?
  • How long do side effects of each treatment option last? Do they go away once treatment is complete?

Learn how the AR-V7 Nucleus Detect test puts AR-targeted therapy to the test

What you can expect from the AR-V7 Nucleus Detect results

See FAQs about the AR-V7 Nucleus Detect test

98%
AR-V7 Nucleus Detect test patients have $0 financial responsibility 

This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Your cost-sharing amounts, including deductibles and copays, will vary by plan and coverage type. Only your insurer can confirm if and how the AR-V7 Nucleus Detect test will be covered.

99%
of AR-V7 Nucleus Detect test patients have a financial responsibility of <$100*

This calculation includes patients with Medicare, Medicare Advantage, Medicaid, Managed Medicaid, and commercial insurance. Patients with high-deductible plans may receive a bill for most or all the cost of the Oncotype DX AR-V7 Nucleus Detect test if they have not satisfied their deductible.

Learn about costs, coverage, and how Exact Sciences can help


*Testing performed at Epic Sciences, Inc., 9381 Judicial Drive, Suite 200, San Diego, CA 92121.
†The numbers cited are based on historical patient billing data from 1/02/2021 to 12/31/2021. Rates of coverage vary by state and region. Exceptions for coverage may apply. Exact Sciences strongly encourages patients to contact their insurer with questions about AR-V7 Nucleus Detect test coverage.